Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2011

01-08-2011 | Original Article

Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with 18F-dopa brain PET in normal controls and patients with Parkinson’s disease

Authors: Liane Oehme, Maria Perick, Bettina Beuthien-Baumann, Martin Wolz, Alexander Storch, Matthias Löhle, Birgit Herting, Jens Langner, Jörg van den Hoff, Heinz Reichmann, Jörg Kotzerke

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2011

Login to get access

Abstract

Purpose

The aim of the study was to estimate normal ranges and test-retest measures for various parameters characterising dopamine metabolism from a prolonged 18F-dopa positron emission tomography (PET) measurement using a reference tissue model and compare their value for the detection of early Parkinson’s disease (PD).

Methods

Healthy volunteers (n = 9) and patients (n = 36) in an early stage of PD underwent an 18F-dopa PET measurement lasting 4 h. The influx rate constant kocc and the effective distribution volume ratio (EDVR, its inverse is an indicator for dopamine turnover) were estimated by a graphical approach using dynamic data in the striatum and, as a reference region, the occipital cortex. Furthermore, ratios of activity concentrations between striatum and occipital brain taken for three time intervals completed the data analysis. All parameters were determined both in eight small volumes of interest placed in the striatum as well as averaged for caudate nucleus and putamen. For the control group, reproducibility was checked in a second study 3 months later and ranges for normal values were derived from mean ± 2 standard deviations. Receiver-operating characteristic (ROC) analyses were performed to assess the value of the parameters for diagnostic purposes.

Results

Patients with early-stage PD and healthy volunteers could be separated by the values of the putamen, not the caudate nucleus. The normal ranges of the putamen were 0.0151–0.0216/min for the influx rate constant kocc and 2.02–3.00 for EDVR. For the various time intervals used the striato-occipital ratios yielded 2.24–3.06, 2.43–3.42 and 2.35–3.21, respectively. Patients were characterised by significantly lower values (p < 0.001) and significant differences between ipsi- and contralateral sides (p < 0.001) with regard to their clinical symptoms and a rostrocaudal gradient. EDVR as well as kocc for the putamen were able to effectively differentiate between groups (sensitivity >97%, specificity 100%). In contrast, striato-occipital ratios showed a sensitivity of about only 85%.

Conclusion

For clinical applications, our data do not demonstrate any superiority of the EDVR determination compared to influx rate constant, while requiring long and tedious acquisition protocols. The normal range estimates do not represent absolute quantitative measures for dopamine metabolism but are specific for the chosen acquisition and processing procedures.
Literature
1.
go back to reference Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998;29:37–61.PubMedCrossRef Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998;29:37–61.PubMedCrossRef
2.
go back to reference Buchert R, Thiele F. The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters. Nuklearmedizin 2008;47:167–74.PubMed Buchert R, Thiele F. The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters. Nuklearmedizin 2008;47:167–74.PubMed
3.
go back to reference Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 1996;16:42–52.PubMedCrossRef Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 1996;16:42–52.PubMedCrossRef
4.
go back to reference Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584–90.PubMedCrossRef Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584–90.PubMedCrossRef
5.
go back to reference Holden JE, Doudet D, Endres CJ, Chan GL, Morrison KS, Vingerhoets FJ, et al. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase. J Nucl Med 1997;38:1568–74.PubMed Holden JE, Doudet D, Endres CJ, Chan GL, Morrison KS, Vingerhoets FJ, et al. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase. J Nucl Med 1997;38:1568–74.PubMed
6.
go back to reference Sossi V, Doudet DJ, Holden JE. A reversible tracer analysis approach to the study of effective dopamine turnover. J Cereb Blood Flow Metab 2001;21:469–76.PubMedCrossRef Sossi V, Doudet DJ, Holden JE. A reversible tracer analysis approach to the study of effective dopamine turnover. J Cereb Blood Flow Metab 2001;21:469–76.PubMedCrossRef
7.
go back to reference Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during PET with FDOPA. Synapse 2001;41:212–8.PubMedCrossRef Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during PET with FDOPA. Synapse 2001;41:212–8.PubMedCrossRef
8.
go back to reference Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, et al. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse 1998;29:225–32.PubMedCrossRef Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, et al. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse 1998;29:225–32.PubMedCrossRef
9.
go back to reference Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, et al. Increase in dopamine turnover occurs early in Parkinson’s disease: evidence from a new modeling approach to PET 18F-fluorodopa data. J Cereb Blood Flow Metab 2002;22:232–9.PubMedCrossRef Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, et al. Increase in dopamine turnover occurs early in Parkinson’s disease: evidence from a new modeling approach to PET 18F-fluorodopa data. J Cereb Blood Flow Metab 2002;22:232–9.PubMedCrossRef
10.
go back to reference Fahn S, Elton RL, UPDRS Development Committee. The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson’s disease. vol 2. Florham Park: Macmillan Health Care Information; 1987. p. 153–163, 293–304. Fahn S, Elton RL, UPDRS Development Committee. The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson’s disease. vol 2. Florham Park: Macmillan Health Care Information; 1987. p. 153–163, 293–304.
11.
go back to reference Hoffman JM, Melega WP, Hawk TC, Grafton SC, Luxen A, Mahoney DK, et al. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med 1992;33:1472–7.PubMed Hoffman JM, Melega WP, Hawk TC, Grafton SC, Luxen A, Mahoney DK, et al. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med 1992;33:1472–7.PubMed
12.
go back to reference Füchtner F, Zessin J, Mäding P, Wüst F. Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11. Nuklearmedizin 2008;47:62–4.PubMed Füchtner F, Zessin J, Mäding P, Wüst F. Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11. Nuklearmedizin 2008;47:62–4.PubMed
13.
go back to reference Füchtner F, Preusche S, Mäding P, Zessin J, Steinbach J. Factors affecting the specific activity of [18F]fluoride from a [18O]water target. Nuklearmedizin 2008;47:116–9.PubMed Füchtner F, Preusche S, Mäding P, Zessin J, Steinbach J. Factors affecting the specific activity of [18F]fluoride from a [18O]water target. Nuklearmedizin 2008;47:116–9.PubMed
14.
go back to reference Langner J, Bühler P, Just U, Pötzsch C, Will E, van den Hoff J. Optimized list-mode acquisition and data processing procedures for ACS2 based PET systems. Z Med Phys 2006;16:75–82.PubMed Langner J, Bühler P, Just U, Pötzsch C, Will E, van den Hoff J. Optimized list-mode acquisition and data processing procedures for ACS2 based PET systems. Z Med Phys 2006;16:75–82.PubMed
15.
go back to reference Bühler P, Just U, Will E, Kotzerke J, van den Hoff J. An accurate method for correction of head movement in PET. IEEE Trans Med Imaging 2004;23:1176–85.PubMedCrossRef Bühler P, Just U, Will E, Kotzerke J, van den Hoff J. An accurate method for correction of head movement in PET. IEEE Trans Med Imaging 2004;23:1176–85.PubMedCrossRef
16.
go back to reference Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD. The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuroimage 2010;50:524–31.PubMedCrossRef Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD. The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. Neuroimage 2010;50:524–31.PubMedCrossRef
17.
go back to reference Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D [(18)F]dopa-PET study. Brain 1999;122(Pt 9):1637–50.PubMedCrossRef Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson’s disease A 3D [(18)F]dopa-PET study. Brain 1999;122(Pt 9):1637–50.PubMedCrossRef
18.
go back to reference Goldstein DS, Holmes C, Sewell L, Kopin IJ. Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity. J Nucl Med 2009;50:1479–82.PubMedCrossRef Goldstein DS, Holmes C, Sewell L, Kopin IJ. Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity. J Nucl Med 2009;50:1479–82.PubMedCrossRef
19.
go back to reference Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls. Eur J Nucl Med Mol Imaging 2009;36:454–62.PubMedCrossRef Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls. Eur J Nucl Med Mol Imaging 2009;36:454–62.PubMedCrossRef
20.
go back to reference Jokinen P, Helenius H, Rauhala E, Brück A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med 2009;50:893–9.PubMedCrossRef Jokinen P, Helenius H, Rauhala E, Brück A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med 2009;50:893–9.PubMedCrossRef
21.
go back to reference Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bönner J, et al. Discordant twins with Parkinson’s disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36:176–82.PubMedCrossRef Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bönner J, et al. Discordant twins with Parkinson’s disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36:176–82.PubMedCrossRef
22.
go back to reference Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, et al. Comparative analysis of striatal FDOPA uptake in Parkinson’s disease: ratio method versus graphical approach. J Nucl Med 2002;43:1324–30.PubMed Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, et al. Comparative analysis of striatal FDOPA uptake in Parkinson’s disease: ratio method versus graphical approach. J Nucl Med 2002;43:1324–30.PubMed
23.
go back to reference Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson’s disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 2006;26:358–70.PubMedCrossRef Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson’s disease: correlation with asymmetry of motor symptoms. J Cereb Blood Flow Metab 2006;26:358–70.PubMedCrossRef
24.
go back to reference Kaasinen V, Nurmi E, Brück A, Eskola O, Bergman J, Solin O, et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex. Brain 2001;124:1125–30.PubMedCrossRef Kaasinen V, Nurmi E, Brück A, Eskola O, Bergman J, Solin O, et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson’s disease: sex differences in the prefrontal cortex. Brain 2001;124:1125–30.PubMedCrossRef
25.
go back to reference Ghaemi M, Rudolf J, Hilker R, Herholz K, Heiss WD. Increased pineal Fdopa uptake is related to severity of Parkinson’s disease–a PET study. J Pineal Res 2001;30:213–9.PubMedCrossRef Ghaemi M, Rudolf J, Hilker R, Herholz K, Heiss WD. Increased pineal Fdopa uptake is related to severity of Parkinson’s disease–a PET study. J Pineal Res 2001;30:213–9.PubMedCrossRef
Metadata
Title
Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with 18F-dopa brain PET in normal controls and patients with Parkinson’s disease
Authors
Liane Oehme
Maria Perick
Bettina Beuthien-Baumann
Martin Wolz
Alexander Storch
Matthias Löhle
Birgit Herting
Jens Langner
Jörg van den Hoff
Heinz Reichmann
Jörg Kotzerke
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1819-8

Other articles of this Issue 8/2011

European Journal of Nuclear Medicine and Molecular Imaging 8/2011 Go to the issue